A NaYbF 4: Tm 3+ nanoprobe for CT and NIR-to-NIR fluorescent bimodal imaging

Biomaterials

Volumn 33, Issue 21, 2012, Pages 5384-5393

  Xing, Huaiyong ^a   Bu, Wenbo ^a,d   Ren, Qingguo ^b   Zheng, Xiangpeng ^b   Li, Ming ^b   Zhang, Shengjian ^c   Qu, Haiyun ^a   Wang, Zheng ^a   Hua, Yanqing ^b   Zhao, Kuaile ^c   Zhou, Liangping ^c   Peng, Weijun ^c   Shi, Jianlin ^a  

^a SHANGHAI INSTITUTE OF CERAMICS   (China)

^b FUDAN UNIVERSITY   (China)

^c FUDAN UNIVERSITY SHANGHAI CANCER CENTER   (China)

^d SHANGHAI JIAO TONG UNIVERSITY   (China)

Author keywords

Contrast medium; CT; NIR fluorescence; Small animal imaging

Indexed keywords

ANIMAL BODY; BIO-IMAGING; CANCEROUS TISSUES; CONTRAST MEDIUM; CT; EARLY DIAGNOSIS; IN-VITRO; NANOPATICLES; NIR ABSORPTIONS; NIR-FLUORESCENCE; SMALL ANIMAL IMAGING;

CONTRAST MEDIA; FLUORESCENCE; NANOPROBES; TISSUE; YTTERBIUM;

INFRARED DEVICES;

CONTRAST MEDIUM; DIAGNOSTIC AGENT; NANOPARTICLE; THULIUM; YTTERBIUM; YTTRIUM;

ANIMAL CELL; ANIMAL EXPERIMENT; ARTICLE; COMPUTER ASSISTED TOMOGRAPHY; CONTROLLED STUDY; CYTOTOXICITY; FLUORESCENCE IMAGING; HUMAN; HUMAN CELL; IN VITRO STUDY; IN VIVO STUDY; MOUSE; NANOPROBE; NEAR INFRARED FLUORESCENCE BIOIMAGING; NONHUMAN; PRIORITY JOURNAL; RADIATION ABSORPTION; TISSUE INJURY; ANIMAL; ANTIBODY SPECIFICITY; CELL DEATH; CELL LINE; CONFOCAL MICROSCOPY; INTRAVENOUS DRUG ADMINISTRATION; METHODOLOGY; NEAR INFRARED SPECTROSCOPY; SPECTROFLUOROMETRY; TIME; TISSUE DISTRIBUTION; ULTRASTRUCTURE; WHOLE BODY IMAGING;

ANIMALIA;

ANIMALS; CELL DEATH; CELL LINE; CONTRAST MEDIA; INJECTIONS, INTRAVENOUS; MICE; MICROSCOPY, CONFOCAL; NANOPARTICLES; ORGAN SPECIFICITY; SPECTROMETRY, FLUORESCENCE; SPECTROSCOPY, NEAR-INFRARED; THULIUM; TIME FACTORS; TISSUE DISTRIBUTION; TOMOGRAPHY, X-RAY COMPUTED; WHOLE BODY IMAGING; YTTERBIUM; YTTRIUM;

EID: 84860915816     PISSN: 01429612     EISSN: 18785905     Source Type: Journal    
DOI: 10.1016/j.biomaterials.2012.04.002     Document Type: Article

References (45)

1. Bourin M., Jolliet P., Ballereau F. An overview of the clinical pharmacokinetics of x-ray contrast media. Clin Pharmacokinet 1997, 32:180-193.
2. Haller C., Hizoh I. The cytotoxicity of iodinated radiocontrast agents on renal cells in vitro. Invest Radiol 2004, 39:149-154.
3. Cai W., Chen X. Nanoplatforms for targeted molecular imaging in living subjects. Small 2007, 3:1840-1854.
4. Pan D., Williams T.A., Senpan A., Allen J.S., Scott M.J., Gaffney P.J., et al. Detecting vascular biosignatures with a colloidal, radio-opaque polymeric nanoparticle. J Am Chem Soc 2009, 131:15522-15527.
5. Aviv H., Bartling S., Kieslling F., Margel S. Radiopaque iodinated copolymeric nanoparticles for X-ray imaging applications. Biomaterials 2009, 30:5610-5616.
6. Galperin A., Margel D., Baniel J., Dank G., Biton H., Margel S. Radiopaque iodinated polymeric nanoparticles for X-ray imaging applications. Biomaterials 2007, 28:4461-4468.
7. Zhou C., Long M., Qin Y., Sun X., Zheng J. Luminescent gold nanoparticles with efficient renal clearance. Angew Chem Int Edit 2011, 50:3168-3172.
8. Kim Y.H., Jeon J., Hong S.H., Rhim W.K., Lee Y.S., Youn H., et al. Tumor targeting and imaging using cyclic RGD-PEGylated gold nanoparticle probes with directly conjugated iodine-125. Small 2011, 7:2052-2060.
9. Kinsella J.M., Jimenez R.E., Karmali P.P., Rush A.M., Kotamraju V.R., Gianneschi N.C., et al. X-ray computed tomography imaging of breast cancer by using targeted peptide-labeled bismuth sulfide nanoparticles. Angew Chem Int Edit 2011, 50:12308-12311.
10. Eck W., Nicholson A.I., Zentgraf H., Semmler W., Sn Bartling Anti-CD4-targeted gold nanoparticles induce specific contrast enhancement of peripheral lymph nodes in X-ray computed tomography of live mice. Nano Lett 2010, 10:2318-2322.
11. Cormode D.P., Fayad Z.A. Nanoparticle contrast agents for CT: their potential and the challenges that lie ahead. Imaging Med 2011, 3:263-266.
12. Wang H., Zheng L., Peng C., Guo R., Shen M., Shi X., et al. Computed tomography imaging of cancer cells using acetylated dendrimer-entrapped gold nanoparticles. Biomaterials 2011, 32:2979-2988.
13. Yu S., Watson A.D. Metal-based X-ray contrast media. Chem Rev 1999, 99:2353-2378.
14. Rabin O., Manuel Perez J., Grimm J., Wojtkiewicz G., Weissleder R. An X-ray computed tomography imaging agent based on long-circulating bismuth sulphide nanoparticles. Nat Mater 2006, 5:118-122.
15. Hainfeld J.F., Slatkin D.N., Focella T.M., Smilowitz H.M. Gold nanoparticles: a new x-ray contrast agent. Brit J Radiol 2006, 79:248-253.
16. Kim D., Park S., Lee J.H., Jeong Y.Y., Jon S. Antibiofouling polymer-coated gold nanoparticles as a contrast agent for in vivo X-ray computed tomography imaging. J Am Chem Soc 2007, 129:7661-7665.
17. 3 nanodots as a contrast agent for in vivo X-ray computed tomography imaging. Adv Mater 2011, 23:4886-4891.
18. Zhao Q., Jiang H., Cao Z., Yang L., Mao H., Lipowska M. A handheld fluorescence molecular tomography system for intraoperative optical imaging of tumor margins. Med Phys 2011, 38:5873-5878.
19. Yokoyama N., Otani T., Hashidate H., Maeda C., Katada T., Sudo N., et al. Real-time detection of hepatic micrometastases from pancreatic cancer by intraoperative fluorescence imaging. Cancer 2011, 10.1002/cncr.26594.
20. Sevick-Muraca E.M. Translation of near-infrared fluorescence imaging technologies: emerging clinical applications. Annu Rev Med 2012, 63:217-231.
21. Santra S., Yang H., Holloway P.H., Stanley J.T., Mericle R.A. Synthesis of water-dispersible fluorescent, radio-opaque, and paramagnetic CdS: Mn/ZnS quantum dots: a multifunctional probe for bioimaging. J Am Chem Soc 2005, 127:1656-1657.
22. Derfus A.M., Chan W.C.W., Bhatia S.N. Probing the cytotoxicity of semiconductor quantum dots. Nano Lett 2003, 4:11-18.
23. Oh M.H., Lee N., Kim H., Park S.P., Piao Y., Lee J., et al. Large-scale synthesis of bioinert tantalum oxide nanoparticles for X-ray computed tomography imaging and bimodal image-guided sentinel lymph node mapping. J Am Chem Soc 2011, 133:5508-5515.
24. Xiong L., Yang T., Yang Y., Xu C., Li F. Long-term in vivo biodistribution imaging and toxicity of polyacrylic acid-coated upconversion nanophosphors. Biomaterials 2010, 31:7078-7085.
25. Haase M., Schäfer H. Upconverting nanoparticles. Angew Chem Int Edit 2011, 50:5808-5829.
26. Zhou J., Liu Z., Li F. Upconversion nanophosphors for small-animal imaging. Chem Soc Rev 2012, 41:1323-1349.
27. 4:Yb, Tm nanocrystals. Biomaterials 2011, 32:9059-9067.
28. Cheng L., Yang K., Shao M.W., Lu X.H., Liu Z. In vivo pharmacokinetics, long-term biodistribution and toxicology study of functionalized upconversion nanoparticles in mice. Nanomedicine 2011, 6:1327-1340.
29. Chen W., Joly A.G., Zhang J.Z. Up-conversion luminescence of Mn2+ in ZnS: Mn2+ nanoparticles. Phys Rev B 2001, 64:041202(1)-041202(4).
30. 2+ in ZnS: Mn2+, Eu3+ codoped nanoparticles. J Appl Phys 2004, 95:667-672.
31. Xing H., Bu W., Zhang S., Zheng X., Li M., Chen F., et al. Multifunctional nanoprobes for upconversion fluorescence, MR and CT trimodal imaging. Biomaterials 2012, 33:1079-1089.
32. Cheung E.N.M., Alvares R.D.A., Oakden W., Chaudhary R., Hill M.L., Pichaandi J., et al. Polymer-stabilized lanthanide fluoride nanoparticle aggregates as contrast agents for magnetic resonance imaging and computed tomography. Chem Mater 2010, 22:4728-4739.
33. 4 upconversion nanocrystals via an OA/ionic liquid two-phase system for in vivo dual-modality imaging. Adv Funct Mater 2011, 21:4470-4477.
34. Wang F., Han Y., Lim C.S., Lu Y.H., Wang J., Xu J., et al. Simultaneous phase and size control of upconversion nanocrystals through lanthanide doping. Nature 2010, 463:1061-1065.
35. http://physics.nist.gov/PhysRefData/XrayMassCoef/.
36. Wang F., Liu X. Recent advances in the chemistry of lanthanide-doped upconversion nanocrystals. Chem Soc Rev 2009, 38:976-989.
37. 3+ nanocrystals with enhanced near-infrared to near-infrared upconversion photoluminescence. ACS Nano 2010, 4:3163-3168.
38. Zhou J., Sun Y., Du X., Xiong L., Hu H., Li F. Dual-modality in vivo imaging using rare-earth nanocrystals with near-infrared to near-infrared (NIR-to-NIR) upconversion luminescence and magnetic resonance properties. Biomaterials 2010, 31:3287-3295.
39. 4 nanoparticles. J Am Chem Soc 2008, 130:5642-5643.
40. 4:Yb, Er/Tm nanocrystals with controllable shape and upconversion fluorescence. Nanotechnology 2008, 19:345606-345610.
41. Huang X., Teng X., Chen D., Tang F., He J. The effect of the shape of mesoporous silica nanoparticles on cellular uptake and cell function. Biomaterials 2010, 31:438-448.
42. Prencipe G., Tabakman S.M., Welsher K., Liu Z., Goodwin A.P., Zhang L., et al. PEG branched polymer for functionalization of nanomaterials with ultralong blood circulation. J Am Chem Soc 2009, 131:4783-4787.
43. He Q., Zhang J., Shi J., Zhu Z., Zhang L., Bu W., et al. The effect of PEGylation of mesoporous silica nanoparticles on nonspecific binding of serum proteins and cellular responses. Biomaterials 2010, 31:1085-1092.
44. Chen Y., Chen H., Sun Y., Zheng Y., Zeng D., Li F., et al. Multifunctional mesoporous composite nanocapsules for highly efficient MRI-guided high-intensity focused ultrasound cancer surgery. Angew Chem Int Edit 2011, 50:12505-12509.
45. Wang X., Chen H., Chen Y., Ma M., Zhang K., Li F., et al. Perfluorohexane-encapsulated mesoporous silica nanocapsules as enhancement agents for highly efficient high intensity focused ultrasound (HIFU). Adv Mater 2012, 24:785-791.